Glycinorm-MR Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Gliclazide

Indications/Uses

Type 2 DM in adults when dietary measures, physical exercise & wt loss alone are not sufficient to control blood glucose.

Dosage/Direction for Use

Adult Initially 30 mg daily. May be increased to 60, 90 or 120 mg daily, in successive steps if blood glucose is not adequately controlled; w/ at least 1 mth interval between each dose increment. Patient whose blood glucose has not reduced after 2 wk of treatment May be increased at the end of the 2nd wk of treatment. Max: 120 mg daily.

Administration

Should be taken with food. Swallow whole. Take at breakfast time.

Contraindications

Hypersensitivity to gliclazide, other sulfonylureas & sulphonamides. Type 1 diabetes. Diabetic pre-coma & coma; diabetic ketoacidosis. Treatment w/ miconazole. Severe renal or hepatic insufficiency. Pregnancy & lactation.

MIMS Class

Antidiabetic Agents

ATC Classification

A10BB09 - gliclazide ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.

Regulatory Classification

POM

Presentation/Packing

Form

Glycinorm-MR tab 60 mg

Packing/Price

1's

Glycinorm-MR

gliclazide

Manufacturer:

IPCA